awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26750456-C696B4EE-BDA1-443B-934D-67C41DA9F901
Q26750456-C696B4EE-BDA1-443B-934D-67C41DA9F901
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750456-C696B4EE-BDA1-443B-934D-67C41DA9F901
Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab
P2860
Q26750456-C696B4EE-BDA1-443B-934D-67C41DA9F901
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750456-C696B4EE-BDA1-443B-934D-67C41DA9F901
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
385fecfc798da9161a3e1b08f21a45f64bbf0292
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.